TP53 and neoplasm: The picture that emerges for HPV-negative HNSCC is of some key driver somatic gene mutations, with each generally associated with considerably less than a quarter of tumours (with the exception of TP53, which is present in a majority (72%)), which then are manifest on a background of other diverse, including passenger, mutations.